EN PL

EMA: Guideline on the conduct of bioequivalence studies for veterinary medicinal products

20.04.2011
It is the objective of this guidance to specify requirements for the design, conduct, and evaluation of bioequivalence studies for pharmaceutical forms with systemic action. In addition, guidance is given on how in-vitro data in specific cases may be used to allow bridging of safety and efficacy data.